THE Singapore dollar plunged to 1.40 against the US unit on Thursday, reflecting growing recession fears as new reported cases of Covid-19 - while slowing down inside China - seem to be picking up pace in the rest of the world.
MAINBOARD-LISTED iFast Corporation is targeting an ambitious 20 per cent return on equity (ROE) from its digital banking outfit in the next five years, with the firm "confident" of receiving a wholesale licence come mid-2020, said its top executive.
FINTECH investments in Singapore more than doubled to US$861 million in 2019 from the year before, led by big gains in funding to payments and insurtech startups.
T- Mobile US and Sprint Corp are nearing an agreement on new merger terms and the final deal could be announced as soon as Thursday, the Wall Street Journal reported citing people familiar with the matter.
Tesla Inc got approval from a German court on Thursday to continue to cut down forest near the capital Berlin to build its first European car and battery factory, in a defeat for local environmental activists.
Twitter Inc said on Thursday that it was testing adding brightly coloured labels underneath tweets posted by politicians and public figures that contain lies and misinformation.
U.S. department store operator Sears has reached a deal for a fresh financial lifeline totaling roughly US$100 million from hedge fund Brigade Capital Management LP, as it tries to stabilize after bankruptcy, people familiar with the matter said on Thursday.
Morgan Stanley said on Thursday it would buy discount brokerage E*Trade Financial Corp in a stock deal worth about US$13 billion, the biggest acquisition by a Wall Street bank since the 2008-2009 financial crisis.
New Mexico Attorney General Hector Balderas on Thursday filed a lawsuit against Alphabet Inc's Google, alleging that it acquired personal information from school children in the state violating their privacy rights.
Canada's drug pricing agency is contemplating significant changes to how it will apply new regulations aimed at lowering costs, Reuters has learned, as drugmakers unhappy with the policy delay introducing new medicines in the country and blame it for job cuts.
